The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis.

Rajshree Pandey,Daniel A. Ollendorf,Katherine Fazioli,Lisa M. Bloudek,Josh J. Carlson,Steven D. Pearson

The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis.

2021

Rajshree Pandey
Daniel A. Ollendorf
Katherine Fazioli
Lisa M. Bloudek
Josh J. Carlson
Steven D. Pearson

DISCLOSURES: Funding for this summary was contributed by Arnold Ventures, California Health Care Foundation, The Donaghue Foundation, Harvard Pilgrim Health Care, and Kaiser Foundation Health Plan ...

Keywords:

Immune Modulators
Ulcerative colitis
health plan
moderate to severe
Medicine
Health care
Family medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations